Filing Details

Accession Number:
0001209191-10-020625
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-05 13:00:00
Reporting Period:
2010-04-01
Filing Date:
2010-04-05
Accepted Time:
2010-04-05 15:16:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1009356 Salix Pharmaceuticals Ltd SLXP Pharmaceutical Preparations (2834) 943267443
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314760 P William Forbes 1700 Perimeter Park Drive
Morrisville NC 27560
V.p. Research& Devel & Cdo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-04-01 1,879 $38.00 60,883 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Option to Buy Common Stock $17.63 2015-06-09 6,250 6,250 Direct
Common Stock Option to Buy Common Stock $17.53 2014-12-16 100,000 100,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-06-09 6,250 6,250 Direct
2014-12-16 100,000 100,000 Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2010.
  2. Options are 100% vested.